Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Vaccine Adjuvants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global vaccine adjuvants market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 12% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Vaccines contain weakened and dead germs that initiate the immune response and activate antigen presenting cells (APCs). This reaction helps the body increase its ability to induce long-term protection and safety against any infection. Vaccine adjuvants are compounds that improve this immunogenic reaction of the body against antigens that have insufficient immunostimulatory capabilities. Aluminum salts and MF59, an oil-in-water emulsion composed of squalene, are among the two common adjuvants that are feasible for human use.

Vaccine Adjuvants Market Trends:

The global vaccine adjuvants market is primarily driven by the rising prevalence of allergies and infectious diseases, including cancer, human immunodeficiency virus (HIV/AIDS), human papillomavirus (HPV) and tuberculosis. The need for advanced treatment options for existing and emerging fatal diseases has resulted in the development of vaccines that have long-lasting effects on immunization. For instance, key manufacturers have developed new adjuvants such as AS01, ISCOM & ISCOMMATRIX, and AS02, which are under clinical trials. Besides this, governments of various countries are taking initiatives for immunization and advancements in adjuvants for human use. They are also focusing on improving healthcare infrastructure and increasing investments for research and development (R&D) of new therapeutics. For example, market players are investing in the development of novel vaccine adjuvants as a potential solution against diseases caused by challenging pathogens, such as malaria and herpes, as well as for vulnerable populations that respond poorly to traditional vaccines, including older adults, neonates, and individuals with compromised immunity and comorbidities. Moreover, with the spread of the coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, there has been an increasing demand for effective and safe vaccine adjuvants. These factors are expected to provide a positive outlook for the market in the upcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global vaccine adjuvants market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type, route of administration, diseases and application.

Breakup by Product Type:

  • Adjuvant Emulsions
  • Pathogen Components
  • Particulate Adjuvants
  • Combination Adjuvants
  • Others
     

Breakup by Route of Administration:

  • Oral
  • Intramuscular
  • Intranasal
  • Subcutaneous
  • Intradermal
  • Others
     

Breakup by Diseases:

  • Cancer
  • Infectious Diseases
  • Others
     

Breakup by Application:

  • Research
  • Commercial
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Adjuvance Tecchnologies Inc., Adjuvatis, Agenus Inc., Brenntag SE, Chemtrade Logistics Inc., CSL Limited, Croda International Plc, Invivogen, Novavax Inc., OZ Biosciences and Virometix AG.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Million
Segment Coverage Product Type, Route of Administration, Diseases, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Adjuvance Tecchnologies Inc., Adjuvatis, Agenus Inc., Brenntag SE, Chemtrade Logistics Inc., CSL Limited, Croda International Plc, Invivogen, Novavax Inc., OZ Biosciences and Virometix AG.
Customization Scope 10% Free Customization
  Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global vaccine adjuvants market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global vaccine adjuvants market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the diseases?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global vaccine adjuvants market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Vaccine Adjuvants Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product Type
    6.1    Adjuvant Emulsions
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Pathogen Components
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Particulate Adjuvants
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Combination Adjuvants
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Route of Administration
    7.1    Oral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Intramuscular
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Intranasal
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Subcutaneous
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Intradermal
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by Diseases
    8.1    Cancer
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Infectious Diseases
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Application
    9.1    Research
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Commercial
        9.2.1 Market Trends
        9.2.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Adjuvance Tecchnologies Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
        15.3.2    Adjuvatis
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Agenus Inc.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Brenntag SE
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
        15.3.5    Chemtrade Logistics Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    CSL Limited
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Croda International Plc
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Invivogen
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Novavax Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    OZ Biosciences
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
        15.3.11    Virometix AG
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio

List of Figures

Figure 1: Global: Vaccine Adjuvants Market: Major Drivers and Challenges
Figure 2: Global: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Global: Vaccine Adjuvants Market: Breakup by Product Type (in %), 2020
Figure 5: Global: Vaccine Adjuvants Market: Breakup by Route of Administration (in %), 2020
Figure 6: Global: Vaccine Adjuvants Market: Breakup by Diseases (in %), 2020
Figure 7: Global: Vaccine Adjuvants Market: Breakup by Application (in %), 2020
Figure 8: Global: Vaccine Adjuvants Market: Breakup by Region (in %), 2020
Figure 9: Global: Vaccine Adjuvants (Adjuvant Emulsions) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Vaccine Adjuvants (Adjuvant Emulsions) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Vaccine Adjuvants (Pathogen Components) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Vaccine Adjuvants (Pathogen Components) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Vaccine Adjuvants (Particulate Adjuvants) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Vaccine Adjuvants (Particulate Adjuvants) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Vaccine Adjuvants (Combination Adjuvants) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Vaccine Adjuvants (Combination Adjuvants) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Vaccine Adjuvants (Other Product Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Vaccine Adjuvants (Other Product Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Vaccine Adjuvants (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Vaccine Adjuvants (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Vaccine Adjuvants (Intramuscular) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Vaccine Adjuvants (Intramuscular) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Vaccine Adjuvants (Intranasal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Vaccine Adjuvants (Intranasal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Vaccine Adjuvants (Subcutaneous) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Vaccine Adjuvants (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Vaccine Adjuvants (Intradermal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Vaccine Adjuvants (Intradermal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Vaccine Adjuvants (Other Routes of Administration) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Vaccine Adjuvants (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Vaccine Adjuvants (Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Vaccine Adjuvants (Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Vaccine Adjuvants (Infectious Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Vaccine Adjuvants (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Vaccine Adjuvants (Other Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Vaccine Adjuvants (Other Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Vaccine Adjuvants (Research) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Vaccine Adjuvants (Research) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Global: Vaccine Adjuvants (Commercial) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Global: Vaccine Adjuvants (Commercial) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: North America: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: North America: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: United States: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: United States: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Canada: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Canada: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Asia-Pacific: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Asia-Pacific: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: China: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: China: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Japan: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Japan: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: India: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: India: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: South Korea: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: South Korea: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Australia: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Australia: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Indonesia: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Indonesia: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Others: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Europe: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Europe: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Germany: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Germany: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: France: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: France: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: United Kingdom: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: United Kingdom: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Italy: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Italy: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Spain: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Spain: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Russia: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Russia: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Others: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Latin America: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Latin America: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Brazil: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Brazil: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Mexico: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Mexico: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Others: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Middle East and Africa: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 88: Middle East and Africa: Vaccine Adjuvants Market: Breakup by Country (in %), 2020
Figure 89: Middle East and Africa: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 90: Global: Vaccine Adjuvants Industry: SWOT Analysis
Figure 91: Global: Vaccine Adjuvants Industry: Value Chain Analysis
Figure 92: Global: Vaccine Adjuvants Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Vaccine Adjuvants Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Vaccine Adjuvants Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
Table 3: Global: Vaccine Adjuvants Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 4: Global: Vaccine Adjuvants Market Forecast: Breakup by Diseases (in Million US$), 2021-2026
Table 5: Global: Vaccine Adjuvants Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 6: Global: Vaccine Adjuvants Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Vaccine Adjuvants Market: Competitive Structure
Table 8: Global: Vaccine Adjuvants Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links